Quantcast
Home > Quotes > TTOO

T2 Biosystems, Inc. Common Stock (TTOO) Quote & Summary Data

TTOO 
$8.52
*  
0.32
3.9%
Get TTOO Alerts
*Delayed - data as of May 21, 2018  -  Find a broker to begin trading TTOO now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
Today's High / Low
$ 8.97 / $ 8.341
Share Volume
769,933
50 Day Avg. Daily Volume
295,806
Previous Close
$ 8.20
52 Week High / Low
$ 8.27 / $ 2.50
Market Cap
306,889,403
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

News for TTOO

Shares Traded

Share Volume:
769,933
50 Day Avg. Daily Volume:
295,806

Trading Range

The current last sale of $8.52

Intraday Last 52 Weeks
High: $ 8.97 $ 8.27
 Low: $ 8.341 $ 2.50

Company Description (as filed with the SEC)

We are an in vitro diagnostics company that has developed an innovative and proprietary technology platform that offers a rapid, sensitive and simple alternative to existing diagnostic methodologies. We are using our T2 Magnetic Resonance technology, or T2MR, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. T2MR enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as low as one colony forming unit per milliliter, or CFU/mL. Our initial development efforts target sepsis and Lyme disease, which are areas of significant unmet medical need in which existing therapies could be more effective with improved diagnostics.  ... More ...  

Risk Grade

Where does TTOO fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 8.61
Open Date:
May 21, 2018
Close Price:
$ 8.20
Close Date:
May 21, 2018

Consensus Recommendation

Analyst Info